{"schema_version":"secwatch.filing_event.v1","accession":"0001576885-24-000067","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.047347+00:00","generated_at":"2026-06-01T06:16:05.997519+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Acumen stockholders elect two Class III directors, ratify Ernst & Young as auditor for FY2024","bullets":["Daniel O'Connell received 40,490,834 votes for, 48,338 withheld; Nathan Fountain 34,164,444 for, 6,371,549 withheld.","Ratification of Ernst & Young as auditor: 52,367,645 for, 7,093 against, 6,271 abstained.","Approximately 87% of outstanding shares (52,381,009 of 60,079,778) were present at the annual meeting.","Directors elected to serve until the 2027 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001576885-24-000067","json":"https://secwatch.observer/filing/0001576885-24-000067.json","markdown":"https://secwatch.observer/filing/0001576885-24-000067.md","text":"https://secwatch.observer/filing/0001576885-24-000067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000067/0001576885-24-000067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000067/abos-20240604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:16:05.997519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}